Is CVE-2024-6523 actively exploited?

CVE-2024-6523 has no public evidence of in-the-wild exploitation as of 2024-11-21.

What is the CVSS score for CVE-2024-6523?

CVE-2024-6523 has a CVSS score of 5.3 (MEDIUM severity). Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X.

How do I patch CVE-2024-6523?

Patch guidance is available from zkteco security advisories. CVEDatabase generates AI-assisted remediation guidance on demand for CVE-2024-6523.

CVE-2024-6523 - remediation guidance & executive summary

Description

A vulnerability was found in ZKTeco BioTime up to 9.5.2. It has been classified as problematic. Affected is an unknown function of the component system-group-add Handler. The manipulation of the argument user with the input <script>alert('XSS')</script> leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. VDB-270366 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

CVSS Metrics

Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Attack Vector: network
Complexity: low
Privileges: low
User Action: none
Confidentiality: undefined
Integrity: undefined
Availability: undefined
Weaknesses: CWE-79 · Cross-site Scripting (XSS)CWE-79 · Cross-site Scripting (XSS)

Metadata

Primary Vendor: ZKTECO
Published: 7/5/2024
Last Modified: 11/21/2024
Source: NIST NVD
Note: Verify all details with official vendor sources before applying patches.

CVE-2024-6523

Description

CVSS Metrics

Metadata

Affected Products

Remediation Guidance

Executive Summary